New hope for smoother recovery after bowel surgery
NCT ID NCT07434310
Summary
This study is testing if continuing a medication called dexmedetomidine for 48 hours after bowel surgery helps people recover better. The goal is to see if it improves comfort, reduces pain, and lessens the need for strong painkillers that often cause nausea and constipation. About 70 adults having planned laparoscopic bowel surgery will be randomly assigned to receive either the medication or a placebo infusion after their operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAPAROSCOPIC ABDOMINAL SURGERIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.